Streetbeat News

Analyst Ratings

ILMN

HSBC analyst Shubhangi Gupta has upgraded Illumina (NASDAQ:ILMN) from Hold to Buy, setting a price target of $180.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 10:24 am

QGEN

HSBC analyst Shubhangi Gupta has downgraded Qiagen (NYSE:QGEN) from Buy to Hold.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 10:22 am

UBER

Daiwa Capital has downgraded Uber Technologies from Outperform to Neutral, setting a price target of $84.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 10:16 am

HST

Compass Point analyst Floris Van Dijkum has upgraded Host Hotels & Resorts (NASDAQ:HST) from Neutral to Buy, setting a price target of $22.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 10:09 am

INMD

BTIG analyst Sam Eiber has initiated coverage on InMode (NASDAQ:INMD) with a Buy rating and set a price target of $25.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 10:06 am

APYX

BTIG analyst Sam Eiber has initiated coverage on Apyx Medical with a Neutral rating, indicating a balanced view on the stock's potential performance.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 9:58 am

AIRS

BTIG has initiated coverage on AirSculpt Technologies with a Neutral rating, indicating a balanced view on the stock's potential performance.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 9:51 am

FWRG

Stephens & Co. has initiated coverage on First Watch Restaurant Group with an Overweight rating and set a price target of $20.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 9:46 am

CYTK

Needham analyst Serge Belanger has reiterated a Buy rating on Cytokinetics (NASDAQ:CYTK) and maintained a price target of $72.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 9:41 am

PCTY

Needham analyst Scott Berg has reiterated a Buy rating on Paylocity Holding (NASDAQ:PCTY) and maintained a price target of $200.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 9:37 am